Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-c
资讯
2024-06-17
VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherap...